Medinice operate in the Medical Technology market concentrating in the fields of cardialogy and cardio surgery. An ever ageing world population, followed by a growing number of health concerns; the need for new solutions and technologies has never been greater. Therefore, continuous development of these products are sought.
Global Cardiovascular Disease Epidemic
According to the New American Heart Association 33 million people in the world suffer from Atrial Fibrillation, the most common cardiac dysrhythmia. The most effective treatment is ablation carried by freezing or burning the problematic area. In the US and throughout Europe there is close to 400 thousand ablation procedures carried out every year; 160 thousand of them to prevent cardiac dysrhythmia.
Ablation procedures have seen an increase of 9% every year; of which 16% of them treat cardiac dysrhythmia. In order to cure AFib related heart disease, each year there are 1.33 million ablation procedures and various implants performed worldwide out of which 800 thousand take place in the European Union and in the US.
Cardiovascular diseases are the most common cause of death in the world.
Cardiovascular disease in the number one cause of death in the world. According to Institute for Health Metrics and Evaluation in 2013 cardiovascular disease was responsible for 32.3% world wide death. Therefore unsurprisingly the same trends are observed in Poland.
Between the years 1990 – 2013 deaths caused by cardiovascular disease grew by 41%.
The Excellent growth potential of Medical Technologies market
Current forecasts predict, the global market for cardiovascular disease will reach $146.4 billion by 2022. With early growth of 2%. Just three of the illnesses: heart failure, heart attack and acute coronary syndrome cases will reach 18.2 billion in 2019.
As a result, these issues combined with an ageing population will result in increased demand for cardiology and cardiac surgery; and markets are set to soar. Cardiology is the second largest segment of the MedTech global market and it is expected to grow at the rate of 5,7% per year to reach $62.3 billion by 2022.